GUERRINI, FRANCESCA Statistiche

GUERRINI, FRANCESCA  

DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE  

Mostra records
Risultati 1 - 20 di 67 (tempo di esecuzione: 0.066 secondi).
Titolo Data di pubblicazione Autore(i) File
A PRACTICAL APPROACH TO THERAPEUTIC DRUG MONITORING OF IMATINIB IN PATIENTS AFFECTED BY CHRONIC MYELOID ELEUKEMIA. THE TIKLET PROTOCOL. 1-gen-2012 Galimberti, Sara; Polillo, M; Baratè, C; Guerrini, Francesca; Cervetti, G; Capecchi, M; Danesi, Romano; Petrini, Mario; DI PAOLO, Antonello
Altered Expression of Jak-Stat Pathway as Possible Predictive Marker in Patients Affected by Chronic Myeloid Leukemia Receiving Tyrosin Kinase Inhibitors (TKIS) 1-gen-2018 Grassi, S; Palumbo, S; Mariotti, V; Ciabatti, E; Guerrini, F; Perutelli, F; Barate, C; Petrini, M; Pellegrini, S; Galimberti, S
Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study. 1-gen-2012 Galimberti, Sara; Guerrini, Francesca; Salvi, F; Petrini, Iacopo; Gioia, D; Messa, E; Palumbo, Ga; Cilloni, D; Petrini, Mario; Levis, A.
The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients 1-gen-2019 Salehzadeh, S.; Guerrini, F.; Pizzano, U.; Grassi, S.; Ciabatti, E.; Iovino, L.; Buda, G.; Caracciolo, F.; Benedetti, E.; Orciuolo, E.; Pelosini, M.; Consani, G.; Carulli, G.; Metelli, M. R.; Martini, Francesca; Mazziotta, F.; Mazzantini, E.; Rossi, Pietro; Tavarozzi, Rita; Ricci, F.; Petrini, M.; Galimberti, S.
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia 1-gen-2017 Galeotti, Laura; Ceccherini, Francesco; Domingo, Dario; Laurino, Marco; Polillo, Marialuisa; DI PAOLO, Antonello; Baratè, Claudia; Fava, Carmen; D'Avolio, Antonio; Cervetti, Giulia; Guerrini, Francesca; Fontanelli, Giulia; Ciabatti, Elena; Grassi, Susanna; Arrigoni, Elena; Danesi, Romano; Petrini, Mario; Cornolti, Fulvio; Saglio, Giuseppe; Galimberti, Sara
The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia 1-gen-2014 DI PAOLO, Antonello; Polillo, Marialuisa; Capecchi, M.; Cervetti, G.; Barate, C.; Angelini, S.; Guerrini, Francesca; Fontanelli, Giulia; Arici, Roberta; Ciabatti, Elena; Grassi, Susanna; Bocci, Guido; Hrelia, P.; Danesi, Romano; Petrini, Mario; Galimberti, Sara
The combination of rituximab and bendamustine as first-line treatment is highly effective in the eradicating minimal residual disease in follicular lymphoma: An Italian retrospective study 1-gen-2017 Galimberti, Sara; Ciabatti, Elena; Ercolano, Giacomo; Grassi, Susanna; Guerrini, Francesca; Cecconi, Nadia; Rousseau, Martina; Cervetti, Giulia; Mazziotta, Francesco; Iovino, Lorenzo; Falzetti, Franca; Falcinelli, Flavio; Bosi, Alberto; Rigacci, Luigi; Kovalchuk, Sofia; Vallisa, Daniele; Macchia, Lucia; Ciancia, Eugenio; Petrini, Mario
Combined FAMD and ANOVA investigation leads to significant association between the hOCT1/ABCB1 diplotype and both efficacy and tolerability in patients affected by chronic myeloid leukemia 1-gen-2015 Galimberti, Sara; Laura, Galeotti; Francesco, Ceccherini; Dario, Domingo; Marco, Laurino; Polillo, Marialuisa; DI PAOLO, Antonello; Claudia, Baratè; Carmen, Fava; Antonio, D'Avolio; Giulia, Fontanelli; Danesi, Romano; Cornolti, Fulvio; Guerrini, Francesca; Ciabatti, Elena; Giuseppe, Saglio; Petrini, Mario
Combined unfavourable polymorphisms ofhOCT1 and ABCG2 are responsible for delayed complete cytogenetic response during imatinib treatment. 1-gen-2014 Galimberti, Sara; Galeotti, L; Ceccherini, F; Laurino, M; Cornolti, Fulvio; Guerrini, Francesca; Ciabatti, Elena; Grassi, S; Baratè, C; Fontanelli, G; Barsotti, S; Ricci, F; Arici, Roberta; Petrini, Mario; Polillo, Ml; DI PAOLO, Antonello
Comparison of Real-Time PCR and Droplet Digital PCR for the Determination of JAK2V617F Mutation in Ph'-Negative Myeloproliferative Neoplasms 1-gen-2014 Fontanelli, Giulia; C., Baratè; Ciabatti, Elena; Guerrini, Francesca; R., Morganti; Arici, Roberta; S., Barsotti; Petrini, Iacopo; DEL RE, Marzia; Petrini, Mario; Galimberti, Sara
Conventional Cytogenetics, ACGH, and PCR as Integrated Workup for a Correct Diagnosis of MDS 1-gen-2016 Galimberti, Sara; Ciabatti, Elena; Valetto, A.; Bertini, V.; Ferreri, Mi; Guazzelli, A; Grassi, Susanna; Guerrini, Francesca; Metelli, Mr; Caligo, Ma; Petrini, Mario
Digital droplet PCR is a specific and sensitive tool for detecting IDH2 mutations in acute myeloid leukemia patients 1-gen-2020 Grassi, S.; Guerrini, F.; Ciabatti, E.; Puccetti, R.; Salehzadeh, S.; Metelli, M. R.; Di Vita, A.; Domenichini, C.; Caracciolo, F.; Orciuolo, E.; Pelosini, M.; Mazzantini, E.; Rossi, P.; Mazziotta, F.; Petrini, M.; Galimberti, S.
Droplet digital PCR represents a new sensitive method for detecting B-RAFV600E mutation at diagnosis and during the follow-up of patients affected by hairy cell leukemia 1-gen-2015 Galimberti, Sara; Paolicchi, Marco; Ghio, Francesco; Cervetti, Giulia; DEL RE, Marzia; Petrini, Iacopo; Ciabatti, Elena; Grassi, Susanna; Metelli, Mariarita; Guerrini, Francesca
The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia 1-gen-2016 Guerrini, Francesca; Paolicchi, Matteo; Ghio, Francesco; Ciabatti, Elena; Grassi, Susanna; Salehzadeh, Serena; Ercolano, Giacomo; Metelli, Maria R.; DEL RE, Marzia; Iovino, Lorenzo; Petrini, Iacopo; Carulli, Giovanni; Cecconi, Nadia; Rousseau, Martina; Cervetti, Giulia; Galimberti, Sara
Evaluation of BCRP and MDR-1 co-expression by quantitative molecular assessment in AML patients 1-gen-2004 Galimberti, Sara; Guerrini, Francesca; Palumbo, Ga; Consoli, U; Fazzi, R; Morabito, F; Santini, V; Petrini, Mario
Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen 1-gen-2007 Galimberti, Sara; Nagy, B; Benedetti, E; Pacini, Simone; Brizzi, S; Caracciolo, F; Papineschi, Federico; Ciabatti, Elena; Guerrini, Francesca; Fazzi, R; Canestraro, Martina; Petrini, Mario
Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen. Leuk Lymphoma 1-gen-2007 Galimberti, Sara; Nagy, B; Benedetti, E; Pacini, Simone; Brizzi, S; Caracciolo, F; Papineschi, Federico; Ciabatti, Elena; Guerrini, Francesca; Fazzi, R; Canestraro, Martina; Petrini, Mario
FLT3 mutations do not influence MDR-1 gene expression in acute myeloid leukemia 1-gen-2003 Galimberti, Sara; Rossi, ANNA MARIA; Palumbo, Ga; Morabito, F; Guerrini, Francesca; Vincelli, I; Fazzi, R; Santini, V; Petrini, Mario
High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naïve lymphocytes and prevents TTV reactivation 1-gen-2018 Iovino, Lorenzo; Mazziotta, Francesco; Carulli, Giovanni; Guerrini, Francesca; Morganti, Riccardo; Mazzotti, Valentina; Maggi, Fabrizio; Macera, Lisa; Orciuolo, Enrico; Buda, Gabriele; Benedetti, Edoardo; Caracciolo, Francesco; Galimberti, Sara; Pistello, Mauro; Petrini, Mario
Highly sensitive MYD88L265P mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia 1-gen-2018 Drandi, Daniela; Genuardi, Elisa; Dogliotti, Irene; Ferrante, Martina; Jiménez, Cristina; Guerrini, Francesca; Schirico, Mariella Lo; Mantoan, Barbara; Muccio, Vittorio; Lia, Giuseppe; Zaccaria, Gian Maria; Omedè, Paola; Passera, Roberto; Orsucci, Lorella; Benevolo, Giulia; Cavallo, Federica; Galimberti, Sara; Sanz, Ramón García; Boccadoro, Mario; Ladetto, Marco; Ferrero, Simone